Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Using External Reference Panel and Single-Variant Summary Statistics for Rare-Variant Aggregation Tests

EF 2022-23

Résumé
Genome-wide association studies (GWAS) are a way for scientists to identify changes in the human genome which are associated with human diseases and traits. We call these changes genetic variants, and GWAS have been successful in identifying thousands of genetic variants which are associated with a wide range of human diseases and traits. However, many of these associations are between common genetic variants and disease. The large majority of the total number of genetic variants humans possess are "rare", and GWAS are often unable to identify associations for these variants. Methods called aggregation tests have been developed to better understand the relationship between rare variants and disease. The findings of GWAS are generally shared to the public via summary statistics. Summary statistics allow researchers to reproduce GWAS results or to perform new analyzes such as aggregation tests. However, current methods to perform aggregation tests using summary statistics require either individual level genetic data or large extra data files. Due to the sensitivity of genetic data and the size of these extra data files, they cannot be shared between studies. This project seeks to bypass this problem by using individual level genetic data from an external panel of individuals. I propose to use a method previously used to do this under a different setting to perform the aggregation tests. I seek to determine the applicability of this method for aggregation tests, and to make recommendations on its use. Data from the UK Biobank will be used to test the method. This dataset contains individual genetic data on ~300,000 people as well as on >3,000 traits and diseases. Current research on the use of external panels in aggregation tests is limited, and if successful this method would allow better understanding of the contribution of rare variants to disease. This could be used to identify individuals at high risk of disease and to develop targeted drug treatments.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Michigan, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
474156
Name
Ryan Brady
Region
Michigan
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Using External Reference Panel and Single-Variant Summary Statistics for Rare-Variant Aggregation Tests
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Aggregation Test; Covariance; Genetics; Genome-Wide Association Study; Rare Variant; Reference Panel; Summary Statistics
Abstract
Genome-wide association studies (GWAS) are a way for scientists to identify changes in the human genome which are associated with human diseases and traits. We call these changes genetic variants, and GWAS have been successful in identifying thousands of genetic variants which are associated with a wide range of human diseases and traits. However, many of these associations are between common genetic variants and disease. The large majority of the total number of genetic variants humans possess are "rare", and GWAS are often unable to identify associations for these variants. Methods called aggregation tests have been developed to better understand the relationship between rare variants and disease. The findings of GWAS are generally shared to the public via summary statistics. Summary statistics allow researchers to reproduce GWAS results or to perform new analyzes such as aggregation tests. However, current methods to perform aggregation tests using summary statistics require either individual level genetic data or large extra data files. Due to the sensitivity of genetic data and the size of these extra data files, they cannot be shared between studies. This project seeks to bypass this problem by using individual level genetic data from an external panel of individuals. I propose to use a method previously used to do this under a different setting to perform the aggregation tests. I seek to determine the applicability of this method for aggregation tests, and to make recommendations on its use. Data from the UK Biobank will be used to test the method. This dataset contains individual genetic data on ~300,000 people as well as on >3,000 traits and diseases. Current research on the use of external panels in aggregation tests is limited, and if successful this method would allow better understanding of the contribution of rare variants to disease. This could be used to identify individuals at high risk of disease and to develop targeted drug treatments.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ryan, Brady
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~